Drug Profile
Research programme: Hedgehog signalling pathway activators - Fate Therapeutics
Latest Information Update: 16 Jul 2016
Price :
$50
*
At a glance
- Originator Fate Therapeutics
- Class Small molecules; Sterols
- Mechanism of Action Hedgehog protein stimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Fracture
Most Recent Events
- 16 Jul 2016 No recent reports of development identified for preclinical development in Fracture in USA
- 26 Aug 2010 Preclinical trials in Fracture in USA (unspecified route)